Apr 18, 2023

The Clinical Laboratory rose to the COVID challenge, but the end of the pandemic has created a new approach to diagnostics. Point of Care and Self Testing are threatening long term demand for clinical lab services but Molecular Diagnostics is driving runaway growth. Understand the opportunities and the threats in this comprehensive report. The fundamentals are still here. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics. A range of dynamic trends are pushing market growth and company valuations. Exciting technical developments especially in the area of molecular diagnostics and pharmacogenomics hold the promise of a dynamic, growing and evolving world market that is moving out of the national and regional orientation and onto a global stage. The report provides data that analysts and planners can use. Hundreds of pages of information including a complete list of Current United States Medicare Fee Payment Schedules to help sharpen your pricing. Forecast demand for new testing regimes or technologies. Make research investment decisions. Based on extensive primary and secondary research the testing volume data is broken down into price and volumes allowing researchers and investors to quickly create informed and reasonable forecasts of demand. Assistance in providing specific growth and market size estimates for new technology tests is normally provided without additional charges. Existing laboratories and hospitals can use the information directly to forecast and plan for clinical facilities growth. Again, assistance in using the information is normally provided without additional charges. Questions? Email us at service at howesoundresearch.com. We would be glad to let you know if we can be of help. Key Topics Covered: 4.3.1 Traditional Automation and Centralization 4.3.2 The New Automation, Decentralization and Point Of Care 4.3.3 Instruments Key to Market Share 4.3.4 Bioinformatics Plays a Role 4.3.5 PCR Takes Command 4.3.7 NGS Impact on Pricing 4.3.8 Whole Genome Sequencing, A Brave New World 4.3.9 Companion Diagnostics Blurs Diagnosis and Treatment 4.3.10 Shifting Role of Diagnostics 5 Clinical Laboratory Services Recent Developments 5.1 Recent Developments - Importance and How to Use This Section 5.1.1 Importance of These Developments 5.1.2 How to Use This Section 5.2 Brooks Automation acquires Aim Lab 5.3 Avalon GloboCare Announces Strategic Investment in Laboratory Services MSO 5.4 Mayo Clinic Laboratories and Helix to provide Biopharma Services 5.5 CompuGroup Medical acquires Medicus Laboratory Information Systems 5.6 Quest Diagnostics acquires Summa Health outreach lab 5.7 Q Solutions Launches Self-Collection Safety Lab Panel 5.8 Bionano Genomics Announces Launch of Bionano Laboratories 5.9 Labcorp to Spin Off Clinical Development Business 5.10 Value-Based Care Growing More Profitable for Labs 5.11 Lucid Diagnostics Reports Revenue Growth 5.12 NGS Cancer Testing Decision Appeases Industry 5.13 Clinical Labs Make Strong Showing in 2021 5.14 Seegene to Enter Syndromic MDx Space 5.15 EKF Diagnostics Acquires Advanced Diagnostic Laboratory 5.16 Molecular Health, EDGC Ink Liquid Biopsy Partnership 5.17 ProPhase Labs Acquires Nebula Genomics for $14.6M 5.18 Karius Cell-Free DNA Method to Detect Infection Validated 5.19 South Korean Firm EDGC to Expand Into Liquid Biopsy Space With Cf DNA Platform 5.20 TruDiagnostic Receives CLIA Certification for Kentucky Laboratory 5.21 Enzo Biochem Q2 Revenues Up 62 Percent 5.22 Thermo Fisher Gets CE Mark for High-Throughput COVID-19 Assay 5.23 FDA Issues Alert - False Negatives due to SARS-CoV-2 Mutations 5.24 Will Labs Use Expanded Molecular Testing Capacities Post-COVID-19? 5.25 Chinese Infectious Dx Firm Vision Medicals Completes Series B Financing 5.26 Cooperative Aims to Expand Clinical, Commercial NGS Access 5.27 CDC Ranks Two More Microbes as 'Urgent Threat' 5.28 ACLA Requests $5 billion to keep private labs going 5.29 Applied Biology to Launch New Laboratory for Hair and Skin Disorders 5.30 Quest Diagnostics Acquires Outreach Operations 6 Profiles of Key Companies 6.1 Acibadem Labmed Laboratory